Dane particle DNA polymerase and HBeAg: Impact on clinical, laboratory, and histologic findings in hepatitis B‐associated chronic liver disease
Ljudevit L. Andres, Vinod K. Sawhney, George H. Scullard, Joseph L. Smith, Thomas C. Merigan, William S. Robinson, Peter B. Gregory – 1 November 1981 – Fifty patients with chronic HBs antigenemia and Dane particle‐associated DNA polymerase and HBeAg in their serum were contrasted to 46 HBsAg positive patients who had neither serum DNA polymerase or HBeAg. The time from acute onset and the duration of antigenemia were longer in patients who were DNA polymerase and HBeAg negative than in those who had both serum markers.